Author:
Tadori Yoshihiro,Kitagawa Hisashi,Forbes Robert A.,McQuade Robert D.,Stark Arlene,Kikuchi Tetsuro
Reference37 articles.
1. A randomized, double-blind, placebo-controlled study of bifeprunox, a partial dopamine D2 receptor agonist, in patients with acute exacerbations of schizophrenia;Barbato;Neuropsychopharmacology,2006
2. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties;Bardin;Neuropsychopharmacology,2006
3. Dopamine agonists in schizophrenia: a review;Benkert;Eur. Neuropsychopharmacol.,1995
4. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase;Bruins Slot;Eur. J. Pharmacol.,2006
5. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors;Burris;J. Pharmacol. Exp. Ther.,2002
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献